Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BIOC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.21
+107%
0.9
vs -12.91
Q4.21
N/A
-5.41
vs 4.2
Q1.22
N/A
-4.80
vs 5.71
Q2.22
N/A
-9.31
vs -4.20
Q3.22
N/A
-9.91
vs 0.9
Q4.22
N/A
-32.57
vs -5.41
Q1.23
N/A
-32.73
vs -4.80
Q2.23
N/A
-3.50
vs -9.31
Q3.23
N/A
-2.36
vs -9.91
Q4.23
+106%
2.09
vs -32.57
Sales Growth
YoY
Current
Estimates
Q3.21
+165%
17.5M vs 6.6M
Q4.21
-24%
14M vs 18.5M
Q1.22
+12%
19.9M vs 17.8M
Q2.22
-12%
10.6M vs 12M
Q3.22
-68%
5.6M vs 17.5M
Q4.22
-174%
-10285000.00 vs 14M
Q1.23
-97%
673K vs 19.9M
Q2.23
-94%
589K vs 10.6M
Q3.23
-89%
601K vs 5.6M
Q4.23
+107%
728.7K vs -10285000
Return on Equity
QoQ
Q3.21
+1%
0.01
vs -0.06
Q4.21
-8%
-0.08
vs 0.01
Q1.22
-7%
-0.07
vs -0.08
Q2.22
-17%
-0.17
vs -0.07
Q3.22
-20%
-0.20
vs -0.17
Q4.22
-209%
-2.09
vs -0.20
Q1.23
-298%
-2.98
vs -2.09
Q2.23
-1252%
-12.52
vs -2.98
Institutionnal Ownership
QoQ
Q3.18
8
8
vs 2
300%
Q4.18
12
12
vs 8
50%
Q1.19
17
17
vs 12
42%
Q2.19
11
11
vs 17
-35%
Q3.19
12
12
vs 11
9%
Q4.19
14
14
vs 12
17%
Q1.20
16
16
vs 14
14%
Q2.20
18
18
vs 16
13%
investorplace.com
7 hours ago
businesswire.com
8 hours ago
businesswire.com
8 hours ago
businesswire.com
8 hours ago
seekingalpha.com
20 hours ago
Quote Panel
Key Metrics
Forecast
2024-Revenue
2024-EPS
2024-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
BIOC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|